Frederiksberg Hospital er et sygehus på Frederiksberg administrativt underlagt Region Hovedstaden. Det har adresse Nordre Fasanvej 57 og er omkranset af Nyelandsvej, Stockflethsvej, Tesdorpsvej, Godthåbsvej og Nordre Fasanvej.

During the past decade, Frederiksberg Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frederiksberg Hospital" #1 sponsor was "Frederiksberg University Hospital" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "Herlev and Gentofte Hospital" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frederiksberg Hospital" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Hillerod Hospital, Denmark" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Frederiksberg Hospital" are "Prostate Cancer" (4 trials), "Rheumatoid Arthritis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Frederiksberg Hospital" in a lesser frequency.

Most popular intervention types in "Frederiksberg Hospital" are "Drug" (27 trials), "Other" (4 trials), "Device" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Adalimumab" (3 trials), "Enzalutamide" (3 trials), "Apixaban Oral Tablet" (2 trials) and "Dabigatran Etexilate Oral Capsule" (2 trials). Other intervention names were less common.

The vast majority of trials in "Frederiksberg Hospital" are 32 trials for "All" genders, 8 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Frederiksberg Hospital". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Frederiksberg Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Frederiksberg Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 6 trials that are defined as “Not Applicable".

Frederiksberg Hospital has several departments that took part in Clinical trials: "Frederiks Hospital, Kardiologisk" - 4 trials, "Urological department, Frederiksberg Hospital" - 2 trials